Drugplain

Insulin Lispro KwikPen 100 [iU]/mL

Insulin lispro · INJECTION, SOLUTION · Eli Lilly and Company

No Recall HistoryCurrently in Shortage
Plain English

Insulin Lispro KwikPen is a injection, solution containing insulin lispro at 100 [iU]/mL, taken intravenous. Manufactured by Eli Lilly and Company.

Key Facts

Brand Name
Insulin Lispro KwikPen
Generic Name
Insulin lispro
NDC Code (Product)
0002-8222
Manufacturer
Eli Lilly and Company
Strength
100 [iU]/mL
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS, SUBCUTANEOUS
Marketing Status
Application #
BLA020563
Drug Class
Insulin Analog [EPC]
Marketing Start
02/12/2020

Recall History

No Recall History

Frequently Asked Questions

What is Insulin Lispro KwikPen used for?

Insulin Lispro KwikPen contains Insulin lispro. It is a injection, solution taken intravenous. Consult your doctor for specific uses.

Is Insulin Lispro KwikPen a controlled substance?

Insulin Lispro KwikPen is not classified as a controlled substance by the DEA.

What is the generic name for Insulin Lispro KwikPen?

The generic name for Insulin Lispro KwikPen is Insulin lispro. There are 12 other brand versions of Insulin lispro.

What is the NDC code for Insulin Lispro KwikPen 100 [iU]/mL?

The NDC (National Drug Code) for Insulin Lispro KwikPen 100 [iU]/mL is 0002-8222, listed by Eli Lilly and Company.